Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
28.6%
% of HRTS's 42 holdings also in CANC
25.0%
% of CANC's 48 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.7% | 4.7% | 4.7% |
|
BRIDGEBIO PHARMA, INC. | 4.2% | 4.1% | 4.1% |
 |
ASTRAZENECA PLC | 3.8% | 5.9% | 3.8% |
|
MERCK & CO. INC. | 3.5% | 4.4% | 3.5% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.4% | 3.6% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to CANC
|
UNITEDHEALTH GROUP INC | 6.1% |
 |
NOVO NORDISK A/S-B | 4.2% |
|
ELI LILLY & CO | 4.0% |
|
VERTEX PHARMACEUTICALS INC | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.0% |
|
ABBOTT LABORATORIES | 3.0% |
|
BOSTON SCIENTIFIC CORP | 2.9% |
|
CYTOKINETICS INC | 2.8% |
 |
MEDTRONIC PLC | 2.5% |
|
CRINETICS PHARMACEUTICALS INC | 2.2% |
HRTS Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -4.3% |
|
GENMAB A/S SPONSORED ADR | -4.1% |
|
EXELIXIS INC | -3.7% |
 |
DAIICHI SANKYO CO LTD | -2.9% |
|
NUVALENT, INC. CLASS A | -2.8% |
|
BEIGENE LTD. SPONSORED ADR | -2.8% |
|
BLUEPRINT MEDICINES CORP. | -2.7% |
|
SUMMIT THERAPEUTICS INC | -2.4% |
|
ILLUMINA INC | -2.1% |
 |
ARGENX SE ADR | -2.1% |